Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/14 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 97
- 較 2021 年第 3 季 −6
- 總值
- $47.1 億
- 較 2021 年第 3 季 +$7.93 億 (+20.2%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ABBVAbbVie Inc. | Stock | 1,985,000 | $2.69 億 | 5.7% | +371,800+23.0% | 加碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 2,715,000 | $2.28 億 | 4.8% | +221,200+8.9% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 2,527,973 | $2.08 億 | 4.4% | +293,273+13.1% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 4,792,000 | $2.02 億 | 4.3% | +1,544,300+47.6% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 2,867,200 | $1.67 億 | 3.5% | +1,455,200+103.1% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 1,140,000 | $1.57 億 | 3.3% | +205,800+22.0% | 加碼 | 歷史 |
| BAXBaxter International Inc | Stock | 1,765,000 | $1.52 億 | 3.2% | +903,000+104.8% | 加碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 321,000 | $1.49 億 | 3.2% | +321,000 | 新進 | 歷史 |
| PFEPfizer Inc | Stock | 2,090,000 | $1.23 億 | 2.6% | +1,063,200+103.5% | 加碼 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 806,400 | $1.18 億 | 2.5% | −256,000−24.1% | 減碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 6,955,000 | $1.16 億 | 2.5% | +2,855,000+69.6% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 535,000 | $1.16 億 | 2.5% | +184,000+52.4% | 加碼 | 歷史 |
| ARNAArena Pharmaceuticals Inc | COM NEW | 1,215,500 | $1.13 億 | 2.4% | +76,500+6.7% | 加碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,012,000 | $1.09 億 | 2.3% | +186,000+22.5% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 1,260,000 | $1.07 億 | 2.3% | +411,100+48.4% | 加碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 995,000 | $1.07 億 | 2.3% | +163,000+19.6% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 685,000 | $1.06 億 | 2.2% | +148,000+27.6% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,823,400 | $1.06 億 | 2.2% | 00.0% | 不變 | 歷史 |
| LLYEli Lilly & Co | Stock | 344,800 | $9,524 萬 | 2.0% | +14,800+4.5% | 加碼 | 歷史 |
| CTLTCatalent, Inc. | COM | 695,000 | $8,898 萬 | 1.9% | +297,000+74.6% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 940,000 | $8,779 萬 | 1.9% | +301,300+47.2% | 加碼 | 歷史 |
| HOLXHologic Inc | COM | 1,064,000 | $8,146 萬 | 1.7% | +118,600+12.5% | 加碼 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 3,780,000 | $7,216 萬 | 1.5% | +2,317,800+158.5% | 加碼 | 歷史 |
| SHCSotera Health Co | COM | 2,960,000 | $6,971 萬 | 1.5% | +582,000+24.5% | 加碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 7,382,488 | $6,275 萬 | 1.3% | +119,000+1.6% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 370,000 | $6,275 萬 | 1.3% | −57,000−13.3% | 減碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 123,100 | $6,181 萬 | 1.3% | +123,100 | 新進 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 280,000 | $6,149 萬 | 1.3% | −646,400−69.8% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,553,000 | $6,035 萬 | 1.3% | +116,000+4.8% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 700,000 | $5,886 萬 | 1.2% | +245,000+53.8% | 加碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 875,000 | $5,801 萬 | 1.2% | +201,300+29.9% | 加碼 | 歷史 |
| STVNStevanato Group S.p.A. | ORD SHS | 2,541,893 | $5,707 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| GRTSGritstone bio, Inc. | COM | 4,370,000 | $5,620 萬 | 1.2% | −87,831−2.0% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 3,228,200 | $5,398 萬 | 1.1% | +2,968,200+1,141.6% | 加碼 | 歷史 |
| ACETAdicet Bio, Inc. | COM | 3,034,004 | $5,307 萬 | 1.1% | +614,404+25.4% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 1,815,000 | $4,314 萬 | 0.9% | +170,000+10.3% | 加碼 | – |
| KYMRKymera Therapeutics, Inc. | COM | 670,000 | $4,254 萬 | 0.9% | +155,500+30.2% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 1,230,000 | $4,212 萬 | 0.9% | +134,400+12.3% | 加碼 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 2,674,067 | $4,035 萬 | 0.9% | +200,000+8.1% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 1,450,000 | $3,950 萬 | 0.8% | +158,000+12.2% | 加碼 | 歷史 |
| OCDXOrtho Clinical Diagnostics Holdings plc | ORD SHS | 1,790,000 | $3,829 萬 | 0.8% | −608,000−25.4% | 減碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,896,000 | $3,729 萬 | 0.8% | +1,896,000 | 新進 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,460,000 | $3,493 萬 | 0.7% | +10,000+0.4% | 加碼 | 歷史 |
| AMNAmn Healthcare Services Inc | COM | 280,100 | $3,427 萬 | 0.7% | +280,100 | 新進 | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 711,900 | $3,318 萬 | 0.7% | −182,100−20.4% | 減碼 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,773,000 | $3,170 萬 | 0.7% | −13,000−0.5% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 3,775,000 | $3,039 萬 | 0.6% | −1,167,000−23.6% | 減碼 | – |
| VIRVir Biotechnology, Inc. | COM | 700,000 | $2,931 萬 | 0.6% | +185,000+35.9% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 775,000 | $2,928 萬 | 0.6% | +775,000 | 新進 | 歷史 |
| SPNESeaSpine Holdings Corp | COM | 2,010,000 | $2,738 萬 | 0.6% | +67,000+3.4% | 加碼 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 2,765,000 | $2,533 萬 | 0.5% | +597,100+27.5% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,278,261 | $2,527 萬 | 0.5% | +1,278,261 | 新進 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 862,000 | $2,523 萬 | 0.5% | +862,000 | 新進 | 歷史 |
| ChemoCentryx, Inc.16383L106 | COM | 644,400 | $2,346 萬 | 0.5% | +644,400 | 新進 | – |
| SIBNSI-BONE, Inc. | COM | 987,400 | $2,193 萬 | 0.5% | +156,200+18.8% | 加碼 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 1,849,538 | $2,103 萬 | 0.4% | +166,097+9.9% | 加碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,345,000 | $1,863 萬 | 0.4% | −587,000−30.4% | 減碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 731,536 | $1,648 萬 | 0.3% | +731,536 | 新進 | 歷史 |
| SCYXScynexis Inc | COM NEW | 2,239,278 | $1,366 萬 | 0.3% | +179,278+8.7% | 加碼 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 851,522 | $1,351 萬 | 0.3% | +112,253+15.2% | 加碼 | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,405,000 | $1,150 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,514,410 | $1,098 萬 | 0.2% | +1,014,410+202.9% | 加碼 | 歷史 |
| SSentinelOne, Inc. | CL A | 208,000 | $1,050 萬 | 0.2% | +8,000+4.0% | 加碼 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 710,000 | $882.5 萬 | 0.2% | −38,995−5.2% | 減碼 | 歷史 |
| Field Trip Health Ord31656R102 | COM | 3,205,000 | $788.4 萬 | 0.2% | −376,000−10.5% | 減碼 | – |
| TNGXTango Therapeutics, Inc. | COM | 705,000 | $771.3 萬 | 0.2% | +405,000+135.0% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 300,000 | $700.2 萬 | 0.1% | −250,000−45.5% | 減碼 | 歷史 |
| TILInstil Bio, Inc. | COM | 408,140 | $698.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 455,037 | $695.8 萬 | 0.1% | +370.0% | 加碼 | 歷史 |
| DHDefinitive Healthcare Corp. | CLASS A COM | 250,000 | $683.3 萬 | 0.1% | +250,000 | 新進 | 歷史 |
| EQRXEQRx, Inc. | COM | 1,000,000 | $682.0 萬 | 0.1% | +1,000,000 | 新進 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 827,402 | $635.4 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 2,000,000 | $634.0 萬 | 0.1% | +2,000,000 | 新進 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 300,000 | $612.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 485,000 | $577.6 萬 | 0.1% | −140,120−22.4% | 減碼 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $503.9 萬 | 0.1% | 00.0% | 不變 | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $495.8 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $493.0 萬 | 0.1% | 00.0% | 不變 | – |
| SNCEScience 37 Holdings, Inc. | COM | 394,000 | $491.3 萬 | 0.1% | +394,000 | 新進 | 歷史 |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $490.0 萬 | 0.1% | 00.0% | 不變 | – |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $485.0 萬 | 0.1% | 00.0% | 不變 | – |
| TRDAEntrada Therapeutics, Inc. | COM | 255,000 | $436.6 萬 | 0.1% | +255,000 | 新進 | 歷史 |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 950,000 | $423.7 萬 | 0.1% | −710,000−42.8% | 減碼 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $403.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $395.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SLGCSomaLogic, Inc. | CLASS A COM | 330,000 | $384.1 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 103,000 | $327.5 萬 | 0.1% | +103,000 | 新進 | 歷史 |
| ONCSOncosec Medical Inc | COM | 2,945,000 | $282.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| AKLIAkili, Inc. | CLASS A ORD SHS | 200,000 | $198.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| PROKProkidney Corp. | CLASS A ORD SHS | 200,000 | $198.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNABSocial Capital Suvretta Holdings Corp. II | CLASS A ORD SHS | 200,000 | $197.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNADSocial Capital Suvretta Holdings Corp. IV | CLASS A ORD SHS | 200,000 | $196.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 165,000 | $140.4 萬 | <0.1% | −1,860,000−91.9% | 減碼 | 歷史 |
| TCRTAlaunos Therapeutics, Inc. | COM | 590,000 | $64.3 萬 | <0.1% | −2,410,000−80.3% | 減碼 | 歷史 |
| SLGCWSomaLogic, Inc. | *W EXP 03/01/202 | 65,999 | $22.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 99,999 | $18.9 萬 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 57,770 | $4.20 萬 | <0.1% | 00.0% | 不變 | – |
2021 年第 3 季之後清倉（21 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 3 季股數 | 2021 年第 3 季市值 | 2021 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | COM | 152,300 | $9,217 萬 | 2.3% | 歷史 |
| EXASExact Sciences Corp | COM | 369,000 | $3,522 萬 | 0.9% | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,162,000 | $3,471 萬 | 0.9% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 251,000 | $3,367 萬 | 0.9% | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 454,000 | $3,291 萬 | 0.8% | 歷史 |
| SANASana Biotechnology, Inc. | COM | 774,644 | $1,745 萬 | 0.4% | 歷史 |
| PATHUiPath, Inc. | Stock | 319,000 | $1,678 萬 | 0.4% | 歷史 |
| LFSTLifeStance Health Group, Inc. | COM | 1,000,000 | $1,450 萬 | 0.4% | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 560,000 | $1,235 萬 | 0.3% | 歷史 |
| ACIUAC Immune SA | SHS | 1,739,600 | $1,167 萬 | 0.3% | 歷史 |
| HARPHarpoon Therapeutics, Inc. | COM | 1,190,600 | $940.6 萬 | 0.2% | 歷史 |
| ESMTEngageSmart, Inc. | COMMON STOCK | 275,000 | $936.7 萬 | 0.2% | 歷史 |
| ORTXOrchard Therapeutics plc | ADS | 3,836,798 | $882.5 萬 | 0.2% | 歷史 |
| ZETAZeta Global Holdings Corp. | CL A | 1,300,000 | $761.8 萬 | 0.2% | 歷史 |
| XLRNAcceleron Pharma Inc | COM | 35,000 | $602.4 萬 | 0.2% | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 145,100 | $574.0 萬 | 0.1% | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 400,000 | $392.0 萬 | 0.1% | 歷史 |
| ZLABZai Lab Ltd | ADR | 35,600 | $375.2 萬 | 0.1% | 歷史 |
| NAUTNautilus Biotechnology, Inc. | COM | 600,000 | $368.4 萬 | 0.1% | 歷史 |
| SGHTSight Sciences, Inc. | COM | 145,189 | $329.6 萬 | 0.1% | 歷史 |
| ATAIAtai Beckley N.V. | SHS | 218,730 | $323.5 萬 | 0.1% | 歷史 |